NASDAQ:STOK - US86150R1077 - Common Stock
Taking everything into account, STOK scores 5 out of 10 in our fundamental rating. STOK was compared to 542 industry peers in the Biotechnology industry. STOK has an excellent financial health rating, but there are some minor concerns on its profitability. STOK has a decent growth rate and is not valued too expensively.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 13.65% | ||
ROE | 15.67% | ||
ROIC | 9.2% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 20.15% | ||
PM (TTM) | 26.26% | ||
GM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | 0 | ||
Altman-Z | 13.15 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 6.98 | ||
Quick Ratio | 6.98 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 22.24 | ||
Fwd PE | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 18.53 | ||
EV/EBITDA | 16.13 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
20.68
+1.05 (+5.35%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 22.24 | ||
Fwd PE | N/A | ||
P/S | 5.67 | ||
P/FCF | 18.53 | ||
P/OCF | 18.4 | ||
P/B | 3.38 | ||
P/tB | 3.38 | ||
EV/EBITDA | 16.13 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 13.65% | ||
ROE | 15.67% | ||
ROCE | 11.65% | ||
ROIC | 9.2% | ||
ROICexc | 32.43% | ||
ROICexgc | 32.43% | ||
OM | 20.15% | ||
PM (TTM) | 26.26% | ||
GM | N/A | ||
FCFM | 30.59% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | 0 | ||
Debt/EBITDA | 0 | ||
Cap/Depr | 22.67% | ||
Cap/Sales | 0.23% | ||
Interest Coverage | 250 | ||
Cash Conversion | 145.71% | ||
Profit Quality | 116.5% | ||
Current Ratio | 6.98 | ||
Quick Ratio | 6.98 | ||
Altman-Z | 13.15 |